Diabetes and non-alcoholic fatty liver disease: a bittersweet symphony

Daniel Clayton-Chubb¹, Stuart K Roberts^{1

2}

Affiliations

Editorial

Daniel Clayton-Chubb et al. Med J Aust. 2023.

. 2023 Oct 16;219(8):353-354.

doi: 10.5694/mja2.52106. Epub 2023 Sep 12.

Daniel Clayton-Chubb¹, Stuart K Roberts^{1

2}

No abstract available

Keywords: Diabetes complications; Diabetes mellitus, type 2; Liver cirrhosis; Liver diseases.

References

1. Adams LA, Roberts SK, Strasser SI, et al. Nonalcoholic fatty liver disease burden: Australia, 2019-2030. J Gastroenterol Hepatol 2020; 35: 1628-1635.
1. Vaz K, Kemp W, Majeed A, et al. Non-alcoholic fatty liver disease prevalence in Australia has risen over 15 years in conjunction with increased prevalence of obesity and reduction in healthy lifestyle. J Gastroenterol Hepatol 2023; https://doi.org/10.1111/jgh.16314 [online ahead of print].
1. Australian Institute of Health and Welfare, Diabetes: Australian facts. Updated 30 June 2023. https://www.aihw.gov.au/reports/diabetes/diabetes/contents/summary (viewed Sept 2023).
1. Australian Institute of Health and Welfare. Overweight and obesity. Updated 19 May 2023. https://www.aihw.gov.au/reports/overweight-obesity/overweight-and-obesit... (viewed Sept 2023).
1. Lazarus JV, Mark HE, Villota-Rivas M, et al; NAFLD policy review collaborators. The global NAFLD policy review and preparedness index: are countries ready to address this silent public health challenge? J Hepatol 2022; 76: 771-780.